American Society of Hirudotherapy

Changes in epithelial cells in Hirudo medicinalis during wound healing

Research article published in Journal of invertebrate pathology (1992)

Last Updated: March 18, 2026Reviewed by: ASH Editorial Board
Research article — evidence reviewArticle reference
Clinical TrialsHuguet G, Molinas M · Journal of invertebrate pathology, 1992

Abstract

In the leech, Hirudo medicinalis, reepithelialization is an event which takes place early in the wound healing process, immediately after the formation of the pseudoblastema, 4-8 hr postinjury. Epithelial cells on the wound margins move into the wound, modifying their phenotypic characteristics. Cells lose their columnar shape and become flattened. Dermal junctions disrupt and tonofilaments regroup around the nucleus. Then, the epithelial cell sheet moves over the newly formed pseudoblastema by extending filopodia, formed by the cells on the edge, following the so-called "sliding model." When the wound is fully covered by the new epithelium, about 24 hr postinjury, a reorganization of the cytoskeleton occurs and the basal dermal junctions are reconstructed. Six days postinjury, the epidermal cells return to their original columnar shape.

Abstract sourced from PubMed (NCBI) for the cited record. See the original publication for the authoritative version.

Publication typeJournal Article
Indexed MeSH termsAnimalsCell MovementEpithelial CellsEpitheliumLeechesMicroscopy, ElectronMicroscopy, Electron, ScanningWound Healing

Summary

In the leech, Hirudo medicinalis, reepithelialization is an event which takes place early in the wound healing process, immediately after the formation of the pseudoblastema, 4-8 hr postinjury.

Why This Matters for Hirudotherapy

Contributes clinical evidence for the therapeutic application of leech therapy.

Citation

Changes in epithelial cells in Hirudo medicinalis during wound healing.

Huguet G, Molinas M · Journal of invertebrate pathology, 1992

Added to ASH library: March 18, 2026 · Site last updated: March 18, 2026

This website provides educational information and does not constitute medical advice, diagnosis, or treatment recommendations. Medicinal leech therapy carries clinically meaningful risks and should be performed only by qualified clinicians under institutionally approved protocols. FDA 510(k) clearance for medicinal leeches is limited to specific indications; investigational and off-label discussions are labeled accordingly. For patient-specific guidance, consult a qualified healthcare provider.

Changes in epithelial cells in Hirudo medicinalis during wound healing | ASH